Regulatory Affairs
NAFDAC Reforms Drive Growth in Local Health-Product Manufacturing, Adeyeye Says
NAFDAC Director-General Prof. Mojisola Adeyeye has highlighted regulatory reforms, rising local manufacturing and new investment partnerships as key developments in Nigeria’s health-products sector.
The National Agency for Food and Drug Administration and Control (NAFDAC) has highlighted regulatory reforms and increased investment as drivers of growth in Nigeria’s local health-products manufacturing sector.
NAFDAC Director-General, Prof. Mojisola Adeyeye, made this known during a presentation at the Invest Nigeria Conference & Expo 4.0, hosted by the Lagos Chamber of Commerce and Industry (LCCI) at Eko Hotels and Suites, Victoria Island, Lagos.
Speaking on “The Roles of NAFDAC with Regards to Investments in Nigeria,” Adeyeye outlined measures introduced by the Agency to strengthen the regulatory environment and support local manufacturing.
She highlighted NAFDAC’s sustained Maturity Level 3 (ML3) status, described as the highest benchmarking rating in Africa, as an important factor in strengthening investor confidence. She also pointed to Nigeria’s attainment of full International Council for Harmonisation (ICH) membership in November 2025.
According to Adeyeye, the Agency’s 5+5 Policy and Ceiling List have also contributed to increased local manufacturing and contract manufacturing partnerships.
Contract manufacturing partnerships increased from 10 companies in 2019 to 87 in 2025, while 176 facility layout reviews had been approved as of June 2026. More than 70 per cent of products covered under the two directives are now locally manufactured, she said.
Adeyeye also highlighted increased foreign direct investment, including joint ventures and technology-transfer arrangements involving companies from India, South Korea and Turkey.
She further referenced the Presidential Executive Order on Local Production as reinforcing the regulatory framework supporting domestic manufacturing.
The NAFDAC Director-General called for continued collaboration among stakeholders and reaffirmed the Agency’s commitment to maintaining a market-friendly regulatory environment that protects public health while supporting investment and strengthening Nigeria’s domestic production capacity.